Hepatic damage caused by coxsackievirus B3 is dependent on age-related tissue tropisms associated with the coxsackievirus-adenovirus receptor

Pathogens and Disease

Volumn 68, Issue 2, 2013, Pages 52-60

  Liu, Jung Yen ^a   Wang, Shih Min ^a,b   Chen, I Chun ^b   Yu, Chun Keung ^a,b   Liu, Ching Chuan ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Coxsackievirus B; Coxsackievirus adenovirus; Hepatitis; Receptor; Receptors.

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR MONOCLONAL ANTIBODY; LACTATE DEHYDROGENASE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL INFILTRATION; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; CYTOTOXICITY; GROWTH RATE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INOCULATION; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER CELL; LIVER INJURY; LIVER NECROSIS; MORTALITY; MOUSE; NICK END LABELING; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; SURVIVAL RATE; VIRAL TROPISM; VIREMIA; VIROGENESIS; VIRUS CULTURE; VIRUS INFECTIVITY; VIRUS PATHOGENESIS;

ANIMALS; BLOOD; CELL LINE; COXSACKIEVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; ENTEROVIRUS B, HUMAN; GENE EXPRESSION PROFILING; HISTOCYTOCHEMISTRY; HUMANS; LIVER; MICE; MICE, INBRED ICR; RECEPTORS, VIRUS; SPLEEN; TAIWAN; VIRAL LOAD; VIRAL TROPISM;

EID: 84884345351     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1111/2049-632X.12044     Document Type: Article

References (34)

1. Abzug MJ (2001) Prognosis for neonates with enterovirus hepatitis and coagulopathy. Pediatr Infect Dis J 20: 758-763.
2. Ahn J, Joo CH, Seo I, Kim D, Hong HN, Kim YK & Lee H (2003) Characteristics of apoptotic cell death induced by coxsackievirus B in permissive Vero cells. Intervirology 46: 245-251.
3. Bergelson JM, Krithivas A, Celi L, Droguett G, Horwitz MS, Wickham T, Crowell RL, & Finberg RW (1998) The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J Virol 72: 415-419.
4. Brown GC, & Karunas RS (1971) Relationship of congenital anomalies and maternal infection with selected enteroviruses. Am J Epidemiol 95: 207-217.
5. Carthy CM, Granville DJ, Watson KA, Anderson DR, Wilson JE, Yang D, Hunt DW, & McManus BM (1998) Caspase activation and specific cleavage of substrates after coxsackievirus B3-induced cytopathic effect in HeLa cells. J Virol 72: 7669-7675.
6. Chang MH, Lee CY, Chen DS, Hsu HC, & Lai MY (1987) Fulminant hepatitis in children in Taiwan: the important role of hepatitis B virus. J Pediatr 111: 34-39.
7. Chen DS, Hsu NHM, Sung JL, Hsu TC, Hsu ST, Kuo YT, Lo KJ, & Shih YT (1987) A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigencarrier mothers. J Am Med Assoc 257: 2597-2603.
8. Chen HL, Chang CJ, Kong MS et al. (2004) Fulminant hepatic failure in children in endemic areas of HBV infection: 15 years after universal hepatitis B vaccination. Hepatology 39: 58-63.
9. Coyne CB, & Bergelson JM (2006) Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124: 119-131.
10. Crowell RL, & Landau BJ (1997) A short history and introductory background on the coxsackieviruses of group B. Curr Top Microbiol Immunol 223: 1-11.
11. Fauquet CM, Mayo MA, Maniloff J, Desselberger U, & Ball LA (2005) Virus Taxonomy: VIIIth Report of the International Committee on Taxonomy of Viruses. Elsevier Academic Press, London.
12. Fechner H, Haack A, Wang H, et al. (1999) Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers. Gene Ther 6: 1520-1535.
13. Fischer R, Poller W, Schultheiss HP, & Gotthardt M (2009) CARdiology- a virus receptor in the healthy and diseased heart. J Mol Med 87: 879-884.
14. Harvala H, Kalimo H, Bergelson J, Stanway G, & Hyypiä T (2005) Tissue tropism of recombinant coxsackieviruses in an adult mouse model. J Gen Virol 86: 1897-1907.
15. Henke A, Launhardt H, Klement K, Stelzner A, Zell R, & Munder T (2000) Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva. J Virol 74: 4284-4290.
16. Hsu HM, Chen DS, & Chuang CH (1988) Efficacy of a mass hepatitis B vaccination program in Taiwan: Studies on 3464 infants of hepatitis B surface antigen-carrier mothers. J Am Med Assoc 260: 2231-2235.
17. Huber SA, Budd RC, Rossner K, & Newell MK (1999) Apoptosis in coxsackievirus B3-induced myocarditis and dilated cardiomyopathy. Ann NY Acad Sci 887: 181-190.
18. Hyypiä T, Hovi T, Knowles NJ, & Stanway G (1997) Classification of enteroviruses based on molecular and biological properties. J Gen Virol 78: 1-11.
19. Ito M, Kodama M, Masuko M, et al. (2000) Expression of coxsackievirus and adenovirus receptor in hearts of rats with experimental autoimmune myocarditis. Circ Res 86: 275-280.
20. Joo CH, Kim YK, Lee H, Hong H, Yoon SY, & Kim D (2002) Coxsackievirus B4-induced neuronal apoptosis in rat cortical cultures. Neurosci Lett 326: 175-178.
21. Kaplan MH, Klein SW, McPhee J, & Harper RG (1983) Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev Infect Dis 5: 1019-1032.
22. Koi H, Zhang J, Makrigiannakis A, Getsios S, MacCalman CD, Kopf GS, Strauss JF 3rd, & Parry S (2001) Differential expression of the coxsackievirus and adenovirus receptor regulates adenovirus infection of the placenta. Biol Reprod 64: 1001-1009.
23. Kunin CM (1962) Virus-tissue union and pathogenesis of enterovirus infections. J Immunol 88: 556-569.
24. Lim BK, Choi JH, Nam JH, Gil CO, Shin JO, Yun SH, Kim DK, & Jeon ES (2006) Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis. Cardiovasc Res 71: 517-526.
25. Pan J, Narayanan B, Shah S, Yoder JD, Cifuente JO, Hafenstein S, & Bergelson JM (2011) Single amino acid changes in the virus capsid permit coxsackievirus B3 to bind decay-accelerating factor. J Virol 85: 7436-7443.
26. Rantakallio P, Lapinleimu K, & Mäntäjarvi R (1970) Coxsackie B5 outbreak in a newborn nursery with 17 cases of serious meningitis. Scand J Infect Dis 2: 17-23.
27. Shieh JT, & Bergelson JM (2002) Interaction with decay-accelerating factor facilitates coxsackievirus B infection of polarized epithelial cells. J Virol 76: 9474-9480.
28. Spiller OB, Goodfellow IG, Evans DJ, Almond JW, & Morgan BP (2000) Echoviruses and coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF. J Infect Dis 181: 340-343.
29. Tomko RP, Xu R, & Philipson L (1997) HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. P Natl Acad Sci USA 94: 3352- 3356.
30. Tomko RP, Johansson CB, Totrov M, Abagyan R, Frisen J, & Philipson L (2000) Expression of the adenovirus receptor and its interaction with the fiber knob. Exp Cell Res 255: 47- 55.
31. Verboon-Maciolek MA, Krediet TG, van Loon AM, Kaan J, Galama JM, Gerards LJ, & Fleer A (2002) Epidemiological survey of neonatal non-polio enterovirus infection in the Netherlands. J Med Virol 66: 241-245.
32. Vincent T, Pettersson RF, Crystal RG, & Leopold PL (2004) Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells. J Virol 78: 8047-8058.
33. Wang SM, Liu CC, Yang YJ, Yang HB, Lin CH, & Wang JR (1998) Fatal coxsackievirus B infection in early infancy characterized by fulminant hepatitis. J Infect 37: 270-273.
34. Wong SN, Tam AYC, Ng THK, Ng WF, Tong CY, & Tang TS (1989) Fatal coxsackie B1 virus infection in neonates. Pediatr Infect Dis J 8: 638-641.